From The Motley Fool · Motley Fool Transcribing · · 2m
Integra Q3 2026 Earnings Report
Integra reports Q3 revenue at $411.2M with Cincinnati flood impact.
In brief
Integra reports Q3 revenue at $411.2M with Cincinnati flood impact. Integra's Q3 revenue grew 2.5% organically to $411.2M despite $7M Cincinnati flood disruption, with full-year 2026 revenue guidance updated to $1.634B-$1.654B. Originally reported by The Motley Fool.
Q3 Revenue
Revenue reached $411.2 million, representing 2.5% organic growth despite $7 million headwind from Cincinnati facility disruption.
Adjusted EPS
Adjusted earnings per share rose to $0.59 from $0.54 in prior year, reflecting revenue growth and cost reductions.
Specialty Surgery
Specialty surgery revenue grew 4.2% organically driven by neurosurgery and international markets.
Neurosurgery Growth
Neurosurgery organic revenue grew 6.5% with strong demand for CereLink, Certas Plus, Bactiseal, and DuraSeal.
International Growth
International specialty surgery revenue grew 7.8% with improved product availability across multiple geographies.
Tissue Reconstruction
Tissue reconstruction revenue declined 2.2% due to competitive pressure in urinary bladder matrix portfolio.
Cincinnati Impact
Cincinnati flooding caused $7 million in lost revenue with $15-$20 million expected impact in Q4.
Debt Refinancing
Completed $2.1 billion debt refinancing on Oct 19, 2026, including $1.65 billion credit facility and $450 million notes.
Full Year Guidance
Full year 2026 revenue guidance updated to $1.634 billion-$1.654 billion with adjusted EPS of $2.30-$2.40.
Operating Cash Flow
Operating cash flow reached $96 million, a record for Q3 driven by lower Braintree startup costs.
Adjusted Gross Margin
Adjusted gross margin fell to 61.1% from 62.9% in prior year due to Cincinnati disruption.
Debt Repayment
Debt repayment of $46 million reduced net debt to $1.5 billion at Q3 end.
SurgiMend Relaunch
SurgiMend relaunch planned for December 2026 with expanded label for breast reconstruction in 2027.
Tissue Reconstruction Recovery
PriMatrix sales remain above 50% of historical revenue levels supporting portfolio recovery.
Interest Expense Impact
Expected $8 million incremental interest expense in Q4 and $24 million increase in 2027 due to refinancing.
Cincinnati Recovery Timeline
Full manufacturing recovery expected by Q2 2027 with limited revenue contribution in Q2 2027.
The takeaway
Integra's Q3 revenue grew 2.5% organically to $411.2M despite $7M Cincinnati flood disruption, with full-year 2026 revenue guidance updated to $1.634B-$1.654B.
